CO[C@@H]1C=C[C@@]23c4cc5c(cc4C(=O)O[C@H]2CN(C)[C@H]3C1)OCO5
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?